Histology
Non-Small Cell Carcinoma
CI-CAN-00001292Explore in graph →
1,752 active trials47 approved drugs589 evidence items
- NCIt
- C65151
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00001292Explore in graph →
Clinical trials
6,757 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,046)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00384826 | Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma | completed | Phase 2 | 133 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Feb 16, 2015 | clinicaltrials |
| NCT01578668 | Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases | completed | Phase 2 | 69 | Guangzhou Medical UniversityOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT00711594 | LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib | completed | Phase 2 | 74 | Boehringer IngelheimINDUSTRY | 1 | Jan 15, 2015 | clinicaltrials |
| NCT01998919 | A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer. | completed | Phase 2 | 154 | Hoffmann-La RocheINDUSTRY | 8 | Jan 13, 2015 | clinicaltrials |
| NCT00400829 | E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2015 | clinicaltrials |
| NCT00735696 | A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer | completed | Phase 2 | 41 | Eli Lilly and CompanyINDUSTRY | 2 | Dec 29, 2014 | clinicaltrials |
| NCT02013206 | A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy | completed | Phase 2 | 52 | Hoffmann-La RocheINDUSTRY | 6 | Dec 19, 2014 | clinicaltrials |
| NCT00160043 | Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer. | completed | Phase 2 | 112 | BayerINDUSTRY | 2 | Dec 16, 2014 | clinicaltrials |
| NCT00160069 | Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer | completed | Phase 2 | 128 | BayerINDUSTRY | 1 | Dec 4, 2014 | clinicaltrials |
| NCT01498562 | Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung Cancer(DATE) | completed | Phase 2 | 160 | Yonsei UniversityOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00240097 | Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC) | completed | Phase 2 | 30 | University of Alabama at BirminghamOTHER | 1 | Nov 27, 2014 | clinicaltrials |
| NCT00800202 | A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis | completed | Phase 2 | 91 | Hoffmann-La RocheINDUSTRY | 1 | Nov 19, 2014 | clinicaltrials |
| NCT01427946 | Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 47 | Infinity Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 13, 2014 | clinicaltrials |
| NCT00531960 | A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer. | completed | Phase 2 | 124 | Hoffmann-La RocheINDUSTRY | 13 | Nov 11, 2014 | clinicaltrials |
| NCT00799240 | MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer(IMPACT) | completed | Phase 2 | 27 | University of KansasOTHER | 1 | Nov 7, 2014 | clinicaltrials |
| NCT01593995 | EGF Ointment for Erlotinib Skin Lesion | completed | Phase 2 | 52 | Dong-A University HospitalOTHER | 1 | Nov 4, 2014 | clinicaltrials |
| NCT00481078 | Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 94 | National Cancer Institute (NCI)NIH | 1 | Oct 30, 2014 | clinicaltrials |
| NCT01844791 | An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients | completed | Phase 2 | 25 | Oncozyme Pharma Inc.INDUSTRY | 1 | Oct 21, 2014 | clinicaltrials |
| NCT00201825 | A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients | completed | Phase 2 | 29 | Tony Bekaii-SaabOTHER | 1 | Oct 6, 2014 | clinicaltrials |
| NCT01473563 | A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 52 | Eli Lilly and CompanyINDUSTRY | 2 | Oct 6, 2014 | clinicaltrials |
| NCT00245063 | AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer | completed | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Oct 2, 2014 | clinicaltrials |
| NCT00986674 | Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 140 | National Cancer Institute (NCI)NIH | 1 | Sep 26, 2014 | clinicaltrials |
| NCT00700180 | A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer. | completed | Phase 2 | 303 | Hoffmann-La RocheINDUSTRY | 16 | Sep 25, 2014 | clinicaltrials |
| NCT01459185 | A Feasibility Study of Oral Adjuvant Chemotherapy With S-1 | completed | Phase 2 | 55 | Tomoshi TsuchiyaOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT01031225 | A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 113 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Sep 19, 2014 | clinicaltrials |
| NCT00118144 | Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00372788 | AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen | completed | Phase 2 | 88 | AstraZenecaINDUSTRY | 3 | Aug 13, 2014 | clinicaltrials |
| NCT01236716 | Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung(C-TONG1002) | completed | Phase 2 | 126 | Chinese Society of Lung CancerOTHER | 1 | Aug 6, 2014 | clinicaltrials |
| NCT00193921 | Chemoradiotherapy in Patients With Localised Lung Cancer | completed | Phase 2 | 82 | Trans Tasman Radiation Oncology GroupOTHER | 1 | Aug 4, 2014 | clinicaltrials |
| NCT00796549 | BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) Patients | completed | Phase 2 | 70 | Boehringer IngelheimINDUSTRY | 1 | Jul 22, 2014 | clinicaltrials |
| NCT00415818 | Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 148 | TransgeneINDUSTRY | 4 | Jul 16, 2014 | clinicaltrials |
| NCT01362296 | An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer | completed | Phase 2 | 134 | GlaxoSmithKlineINDUSTRY | 8 | Jul 11, 2014 | clinicaltrials |
| NCT00661778 | A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 50 | Hoffmann-La RocheINDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT01240447 | Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients | completed | Phase 2 | 7 | Laboratorio Elea Phoenix S.A.INDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT01996332 | A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 1,805 | Hoffmann-La RocheINDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT00620971 | Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC | completed | Phase 2 | 77 | Hellenic Oncology Research GroupOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00368927 | Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia | completed | Phase 2 | 61 | National Cancer Institute (NCI)NIH | 2 | May 23, 2014 | clinicaltrials |
| NCT00778167 | Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT01004250 | A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer | completed | Phase 2 | 109 | Eli Lilly and CompanyINDUSTRY | 5 | May 21, 2014 | clinicaltrials |
| NCT01362400 | A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 226 | Infinity Pharmaceuticals, Inc.INDUSTRY | 6 | May 19, 2014 | clinicaltrials |
| NCT00406302 | Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC) | completed | Phase 2 | 41 | Wolfgang HilbeOTHER | 1 | Apr 29, 2014 | clinicaltrials |
| NCT01000480 | A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer | completed | Phase 2 | 90 | Eli Lilly and CompanyINDUSTRY | 4 | Apr 2, 2014 | clinicaltrials |
| NCT00730925 | Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC Patients | completed | Phase 2 | 41 | Boehringer IngelheimINDUSTRY | 2 | Mar 26, 2014 | clinicaltrials |
| NCT00247416 | Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer | completed | Phase 2 | 60 | Susanne ArnoldOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00995761 | Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 48 | Gyeongsang National University HospitalOTHER | 1 | Mar 3, 2014 | clinicaltrials |
| NCT01516983 | Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation | completed | Phase 1 / Phase 2 | 15 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 17, 2014 | clinicaltrials |
| NCT00256815 | Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study | completed | Phase 1 / Phase 2 | 35 | Clinical Oncology Research AssociatesOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT00171834 | Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 89 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 5, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Feb 16, 2015source: clinicaltrials